Pacers’ LeVert undergoes cancer surgery

Caris LeVert, the Indiana Pacers’ recent acquisition in a trade who flunked his physical, has been diagnosed with renal cell carcinoma and underwent surgery, it was announced Tuesday.

The new player, obtained in a multiteam trade that sent Victor Oladipo to the Houston Rockets, was sidelined after doctors discovered a mass on his left kidney last week.

The NBA club termed the cancer operation performed Monday as “successful surgery” at Community North Hospital in Indianapolis.

Uncertainty surrounded LeVert’s long-term prognosis, but the team’s statement indicated “Caris is expected to make a full recovery.” It was also stated, “No further treatment is needed.”

Renal cell carcinoma more often is a cancer that shows up in older men and can be exacerbated by smoking or obesity. LeVert is 26 and is 6-foot-6 and weighs about 205 pounds.

LeVert, a guard who played for four-plus seasons with the Brooklyn Nets, has a career average of 13.1 points a game but more recently has been averaging more than 18 per game. He was originally drafted in the first round by the Pacers in 2016 but was traded away before playing for Indiana.

There was no indication of when the Pacers might expect LeVert to play for the team. The statement said only he will be out indefinitely.